TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/24/24 16:18 | 1/23/24 | AURA | Aura Biosciences, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Feder Julie B | MA | O | CFO | S | -51 | 7.64 | 0 | -7 | -9 | 63 | D | ||||||||||||||
11/7/23 18:09 | 11/6/23 | AURA | Aura Biosciences, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Feder Julie B | MA | O | CFO | M.d | 11 | 2.74 | 0 | 4 | 6 | 70 | D | ||||||||||||||
11/7/23 18:09 | 11/6/23 | AURA | Aura Biosciences, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Feder Julie B | MA | O | CFO | S.d | -47 | 12.07 | 0 | -4 | -5 | 70 | D | ||||||||||||||
11/1/23 18:24 | 10/30/23 | AURA | Aura Biosciences, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Feder Julie B | MA | O | CFO | S | -23 | 6.82 | 0 | -3 | -5 | 70 | D | ||||||||||||||
11/2/22 20:39 | 10/31/22 | AURA | Aura Biosciences, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Feder Julie B | MA | O | CFO | S | -25 | 12.45 | 0 | -2 | -8 | 24 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |